Eastman Chemical Company
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EMN research report →
Range $62 – $85
Price Chart
About the company
Eastman Chemical Company functions as a worldwide provider of specialized materials. Its Additives & Functional Products division offers a comprehensive range, including hydrocarbon and rosin resins, organic acid-based solutions, and amine-derived building blocks. This segment also provides agricultural chemicals like metam-based soil fumigants, thiram and ziram fungicides, and plant growth regulators.
- CEO
- Mark J. Costa
- IPO
- 1993
- Employees
- 13,000
- HQ
- Kingsport, TN, US
Get TickerSpark's AI analysis on EMN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $6.72B
- P/E
- 10.37
- Fwd P/E
- 9.62
- PEG
- -1.61
- P/S
- 0.74
- P/B
- 1.07
- EV/EBITDA
- 8.02
- Div Yield
- 5.72%
- Gross Margin
- 20.57%
- Op Margin
- 10.08%
- Net Margin
- 7.15%
- ROE
- 10.63%
- ROIC
- 6.74%
Latest fiscal year · YoY change
- Revenue
- $8.75B-6.7%
- Gross Profit
- $1.84B-19.5%
- Op Income
- $931.00M
- Net Income
- $474.00M-47.6%
- EPS
- $4.13-46.7%
- OCF Growth
- -24.6%
- FCF Growth
- -38.4%
- 52W High
- $83.47
- 52W Low
- $56.69
- 50D MA
- $64.99
- 200D MA
- $70.63
- Beta
- 1.08
- RSI (14)
- 30
- Avg Volume
- 1.26M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Eastman said Q3 was pressured by startup delays and a sharp raw-material squeeze, but it still sees volume growth and better cash flow ahead, helped by the restored DOE grant and circular-economy projects.· October 30, 2026
- DOE grant was restored at full value, with Eastman saying the agency could fund up to 50% of the capital for the combined Kingsport expansion and second plant.
- Q3 was hurt by about a month of delays on the Tritan line and a PET polymer-line conversion, which caused extra costs and some lost sales.
- Management said Advanced Materials should finish the year at about 3% volume/mix growth, despite weak autos, China performance-film pressure, and a roughly $15 million Q4 headwind from higher PX.
- Operating cash flow was revised to about $850 million for the year, with working capital expected to release in Q4 and support stronger 2027 cash flow.
- Eastman expects next year to bring volume growth in Advanced Materials, AFP, and Fibers, while Chemical Intermediates should be roughly similar to this year and circular sales move higher.
The transcript did not include the company’s reported Q3 revenue, EPS, or gross margin figures. Management did state that full-year operating cash flow is now expected to be about $850 million, down from $900 million, and that year-to-date working capital has built by $560 million. In Advanced Materials, management cited about a $15 million headwind in Q4 tied to higher PX and said the full-year price/cost impact for the segment is about a $30 million headwind. For circular growth, Eastman said it expects up to about $100 million of revenue this year, with roughly $20 million of incremental earnings from that platform. Looking ahead, the company said next-year volume growth is expected in AM, AFP, and Fibers, while CI volumes should be similar to this year; CapEx for 2027 was described as remaining within plan, with this year’s spend expected around $400 million and a baseline starting point around $500 million for broader circular investments.
Mark Costa framed the quarter around execution in a difficult macro backdrop, with high oil/raw-material volatility, weak autos and durable goods, and caution tied to the Iran conflict. His tone was optimistic on strategy: he emphasized the restored DOE partnership, lower-capital circular investments, the ability to reuse underutilized assets, and the long-term value of the methanolysis, recycling, and metathesis projects. He repeatedly stressed discipline on capital allocation while saying Eastman can still drive growth in revenue, earnings, and cash flow.
Willie McLain focused on cash flow, working capital, and capital planning. He said working capital was up almost $500 million year-to-date, specifically $560 million, and expects a release in Q4 as inventory normalizes and turnaround timing rolls through. He reiterated full-year operating cash flow of about $850 million, noted year-end inventory days fell from about 115 at year-end 2025 to about 105 at the end of Q3, and said the DOE support should keep 2027 CapEx within plan for the first phase while effectively cutting future additional investments by roughly 50% for the broader circular buildout. He also said this year’s CapEx is expected around $400 million, with a baseline starting point around $500 million for the broader circular expansion.
Analysts pressed on the DOE grant, asking how much capital it could offset and whether the scope now includes debottlenecking the existing methanolysis plant, feedstock processing, polymer lines, and second-plant assets. Management said the grant can cover up to 50% of qualifying capital, that the scope is broader than the original Longview plan, and that it should reduce near-term CapEx while improving capital efficiency. Questions also focused on Advanced Materials price/cost, startup delays, circular revenue growth into 2027, cash flow, inventory, and the propane/propylene spread in CI. Management said the Tritan and PET line issues were only a Q3 problem, that Q4 should not be affected, that Q4 is not a good proxy for CI because the spread is unusually distorted, and that 2027 should benefit from better volumes, normalized spreads, and working-capital release.
The positive case from the call is that Eastman still sees multiple growth engines working despite a weak macro backdrop: Advanced Materials volume/mix growth, expanding circular revenue, and improving utilization in Fibers and AFP. Management also sounded constructive that the DOE grant lowers capital intensity and that working capital can unwind into stronger 2027 cash flow. The company said it expects more stable or improving conditions in several areas next year, including CI and volume growth across key segments.
The main risks are the same ones management kept returning to: weak end markets, especially autos, construction, and consumer durables; volatile raw-material and energy spreads; and uncertainty tied to the Iran conflict. Q3 also showed execution risk, with startup delays on key lines hurting both costs and sales. In addition, management acknowledged pressure in performance films and acetate tow, plus a still-uncertain economic outlook that could affect customer behavior and the timing of volume recovery.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.1%
- Shares Outstanding
- 114.33M
- Float Shares
- 113.31M
of shares held by institutions
670 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for EMN, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Lisa C. McClainHouse · MI09 | Sell | Aug 4, 25 | Filing → |
| Lisa C. McClainHouse · MI09 | Buy | Jun 17, 25 | Filing → |
| Robert P. BresnahanHouse · PA08 | Sell | May 15, 25 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Feb 10, 23 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Jan 9, 23 | Filing → |
| Kathy E. ManningHouse · NC06 | Sell | Aug 3, 22 | Filing → |
| Kathy E. ManningHouse · NC06 | Buy | Jul 20, 22 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Jun 27, 22 | Filing → |
| Ro KhannaHouse · CA17 | Buy | May 10, 22 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Apr 13, 22 | Filing → |
| John Henry RutherfordHouse · FL04 | Sell | Mar 16, 22 | Filing → |
| Peter MeijerHouse · MI03 | Sell | Feb 16, 21 | Filing → |
| Dean PhillipsHouse · MN03 | Buy | Apr 2, 20 | Filing → |
| Gilbert CisnerosHouse · CA31 | Sell | Mar 18, 20 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 18.23M | ▲ 1.30M |
| Vanguard Group Inc | 13.27M | ▼ 1.07M |
| Vanguard Portfolio Management LLC | 7.12M | ▼ 433.89K |
| Dimensional Fund Advisors LP | 5.44M | ▲ 271.88K |
| Vanguard Capital Management LLC | 5.14M | ▼ 23.80K |
| State Street Corp | 4.23M | ▲ 58.92K |
| Morgan Stanley | 2.97M | ▼ 358.08K |
| Boston Partners | 2.80M | ▲ 1.30M |
| Massachusetts Financial Services Co | 2.71M | ▲ 44.79K |
| Bank Of America Corp | 2.43M | ▼ 39.56K |
| Earnest Partners LLC | 2.33M | ▼ 67.95K |
| Two Sigma Investments, LP | 2.27M | ▲ 669.00K |
Held by 504 ETFs
Biggest fund positions in EMN by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 6, 26 | McAlindon Julie A. | buy | 2,451 |
| Oct 7, 26 | Haynesworth Linnie M | other | 480 |
| Oct 7, 26 | BUTLER ERIC L | other | 480 |
| Oct 7, 26 | SLAGER DONALD W | other | 480 |
| Oct 7, 26 | BEGEMANN BRETT D | other | 480 |
| Oct 7, 26 | BEGEMANN BRETT D | other | 1,362 |
| Oct 7, 26 | Audia Damon J | other | 480 |
| Oct 7, 26 | Audia Damon J | other | 1,002 |
| Oct 7, 26 | Holder Julie Fasone | other | 480 |
| Oct 7, 26 | Mink Kim Ann | other | 480 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our EMN coverage
Recent articles, reports, and earnings notes.
No research on EMN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate EMN report →$400,000 in These 4 Dividend Stocks Could Pay $21,000 a Year, but 2 Already Cut Payouts
247wallst.com · Nov 20
4 Chemical and Materials Stocks Yielding Over 4% for Retirees Who Want Income
247wallst.com · Nov 20
Sector Defense And 15 Valuation Mid-November Winners Up To 7.4%
seekingalpha.com · Nov 19
Wall Street's Most Accurate Analysts Give Their Take On 3 Materials Stocks Delivering High-Dividend Yields
benzinga.com · Nov 12
2 Chemical Giants Cut Their Dividends. This Third Stock Kept Raising
247wallst.com · Nov 9
Don't Overlook Eastman Chemical (EMN) International Revenue Trends While Assessing the Stock
zacks.com · Nov 2
What Eastman Chemical (EMN) Said on Its Q3 Earnings Call
marketbeat.com · Oct 30
Eastman Chemical Company (EMN) Q3 2026 Earnings Call Transcript
seekingalpha.com · Oct 30
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.